Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients
暂无分享,去创建一个
P. Pereira | T. Helmberger | P. Lucatelli | A. Baierl | S. Spiliopoulos | J. Taieb | D. Arnold | R. Iezzi | Z. Bánsághi | Bleranda Zeka | F. Carchesio | N. Kaufmann | A. Gjoreski | Ivona Jovanoska